Yuejie Zhu

Ueruemqi, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Biosynthetic composite iron minerals enhance electroactive biofilm activity and stability by reducing charge transfer resistance and buffering the internal acid inhibition.

Biosynthetic composite iron minerals enhance electroactive biofilm activity and stability by reducing charge transfer resistance and buffering the internal acid inhibition.

Journal: Bioresource technology
Published: May 06, 2026

Oral Brucella melitensis infection leads to persistent bacterial colonisation and dynamic histopathology in reproductive and immune organs of female mice.

Oral Brucella melitensis infection leads to persistent bacterial colonisation and dynamic histopathology in reproductive and immune organs of female mice.

Journal: Frontiers in microbiology
Published: May 03, 2026

Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.

Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.

Journal: Journal of nanobiotechnology
Published: April 14, 2026

Leveraging ligand density and multivalent binding for optimal mannose targeting of APCs in precision vaccines.

Leveraging ligand density and multivalent binding for optimal mannose targeting of APCs in precision vaccines.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: April 04, 2026

Myeloid-derived suppressor cells and their subsets serve as potential biomarkers for the progression of brucellosis.

Myeloid-derived suppressor cells and their subsets serve as potential biomarkers for the progression of brucellosis.

Journal: Frontiers in microbiology
Published: October 28, 2025

Tuft-cell-derived IL-25 regulates intestinal ILC2 in response to Brucella infection.

Tuft-cell-derived IL-25 regulates intestinal ILC2 in response to Brucella infection.

Journal: Frontiers in immunology
Published: October 25, 2025

Siglec-9 acts as an immune checkpoint marker on MDSCs in brucella infection.

Siglec-9 acts as an immune checkpoint marker on MDSCs in brucella infection.

Journal: Frontiers in cellular and infection microbiology
Published: June 23, 2025

Correction: Regulation of the tuft cell-ILC2 circuit in intestinal mucosal immunity.

Correction: Regulation of the tuft cell-ILC2 circuit in intestinal mucosal immunity.

Journal: Frontiers in immunology
Published: May 27, 2025

FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella.

FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella.

Journal: Vaccines
Published: March 31, 2025

Design of a multi-epitope recombinant BCG vaccine targeting Brucella OMP31, LptE and VirB2 in immunoinformatics approaches.

Design of a multi-epitope recombinant BCG vaccine targeting Brucella OMP31, LptE and VirB2 in immunoinformatics approaches.

Journal: PloS one
Published: March 12, 2025

Development and evaluation of novel Brucella diagnostic antigen protein ST.

Development and evaluation of novel Brucella diagnostic antigen protein ST.

Journal: BMC infectious diseases
Published: March 04, 2025

Construction of a multi-epitope vaccine against Helicobacter pylori fused with the CTLA-4 extracellular domain and expressed in BCG.

Construction of a multi-epitope vaccine against Helicobacter pylori fused with the CTLA-4 extracellular domain and expressed in BCG.

Journal: Gene
Published: February 15, 2025
Showing 1-12 of 46

Last Updated: 09/26/2026